Literature DB >> 17357846

Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis.

Rana Hajizadeh1, Hiroe Sato, James Carlisle, Michele T Nadaf, Whitney Evans, Bryan E Shepherd, Robert F Miller, Spyros A Kalams, Wonder Puryear Drake.   

Abstract

Sarcoidosis is a granulomatous disease of unknown etiology, characterized by a Th-1 immunophenotype. Although humoral immune responses by sarcoidosis subjects to mycobacterial proteins have been detected, mycobacterial antigens capable of inducing cellular immune responses in sarcoidosis subjects have not been reported. We used the enzyme-linked immunospot assay to assess for recognition of the Mycobacterium tuberculosis mycolyl transferase, Antigen 85A, by peripheral blood mononuclear cells from 25 sarcoidosis subjects, 22 PPD- (purified protein derivative) healthy volunteers, and 16 PPD+ healthy subjects. Reactivity to Ag85A whole protein was observed in 15 of 25 sarcoidosis subjects compared to 2 of 22 PPD- subjects (p=0.0006, Fisher's exact test) and to 14 of 16 PPD+ subjects (p=0.084, Fisher's exact test). Monoclonal antibody against HLA-DR inhibited recognition. In addition to immune recognition of Ag85A whole protein, peptide-mapping studies identified four immunogenic Ag85A peptides, which induced Th-1 immune responses in individual sarcoidosis subjects, suggesting that multiple epitopes from a mycobacterial protein may have a role in sarcoidosis immunopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357846      PMCID: PMC3962023          DOI: 10.1007/s10875-007-9080-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.

Authors:  L Y Armitige; C Jagannath; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.

Authors:  M A Altfeld; B Livingston; N Reshamwala; P T Nguyen; M M Addo; A Shea; M Newman; J Fikes; J Sidney; P Wentworth; R Chesnut; R L Eldridge; E S Rosenberg; G K Robbins; C Brander; P E Sax; S Boswell; T Flynn; S Buchbinder; P J Goulder; B D Walker; A Sette; S A Kalams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.

Authors:  A S Mustafa; F A Shaban; A T Abal; R Al-Attiyah; H G Wiker; K E Lundin; F Oftung; K Huygen
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

5.  Epidemiological trends in tuberculosis and sarcoidosis in a district of London between 1958 and 1963.

Authors:  G Z Brett
Journal:  Tubercle       Date:  1965-12

6.  Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis.

Authors:  Wonder P Drake; Mary S Dhason; Michele Nadaf; Bryan E Shepherd; Sangeetha Vadivelu; Rana Hajizadeh; Lee S Newman; Spyros A Kalams
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

7.  Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis.

Authors:  C M Greene; G Meachery; C C Taggart; C P Rooney; R Coakley; S J O'Neill; N G McElvaney
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

8.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

9.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

Authors:  B W Robinson; T L McLemore; R G Crystal
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.

Authors:  P J Goulder; Y Tang; C Brander; M R Betts; M Altfeld; K Annamalai; A Trocha; S He; E S Rosenberg; G Ogg; C A O'Callaghan; S A Kalams; R E McKinney; K Mayer; R A Koup; S I Pelton; S K Burchett; K McIntosh; B D Walker
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  23 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Sarcoidosis and the occurrence of malignant diseases.

Authors:  Norbert Blank; Hanns-Martin Lorenz; Anthony D Ho; Mathias Witzens-Harig
Journal:  Rheumatol Int       Date:  2014-03-23       Impact factor: 2.631

4.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

Review 5.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

Review 6.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

7.  Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Xiaoyan Zhan; Christa F Gaskill; Susamma Abraham; Cathy Jenkins; Daniel A Culver; Wonder Drake
Journal:  Respir Res       Date:  2010-11-23

8.  Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells.

Authors:  J Carlisle; W Evans; R Hajizadeh; M Nadaf; B Shepherd; R D Ott; K Richter; W Drake
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

9.  Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.

Authors:  Wonder P Drake; Kyra Oswald-Richter; Bradley W Richmond; Joan Isom; Victoria E Burke; Holly Algood; Nicole Braun; Thyneice Taylor; Kusum V Pandit; Caroline Aboud; Chang Yu; Naftali Kaminski; Alan S Boyd; Lloyd E King
Journal:  JAMA Dermatol       Date:  2013-09       Impact factor: 10.282

10.  Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis.

Authors:  Takeshi Hattori; Satoshi Konno; Ayumu Takahashi; Akira Isada; Kaoruko Shimizu; Kenichi Shimizu; Natsuko Taniguchi; Peisong Gao; Etsuro Yamaguchi; Nobuyuki Hizawa; Shau-Ku Huang; Masaharu Nishimura
Journal:  BMC Med Genet       Date:  2010-10-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.